CLINICAL LASERTHERMIA SYSTEMS
Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for CLS’ own immunostimulating therapy, imILT®. The company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA. CLS is listed on Nasdaq First North under the stock symbol CLS B.
CLINICAL LASERTHERMIA SYSTEMS
Industry:
Biotechnology Laser Medical Device Therapeutics
Founded:
2006-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.clinicallaser.se
Total Employee:
11+
Status:
Active
Contact:
046-15 21 00
Email Addresses:
[email protected]
Total Funding:
2.14 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Clinical Laserthermia Systems
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-12 | Clinical Laserthermia Systems appoints new CFO |
Official Site Inspections
http://www.clinicallaser.se
- Host name: izanami.oderland.com
- IP address: 91.201.60.135
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Clinical Laserthermia Systems"
Executive Management Team - CLS
Executive Management Team CLS’ management team has extensive experience in product and business development of medtech products, as well as in cancer care, regulatory work and …See details»
About CLS - CLS
Read about CLS’ exciting journey from 2006 until now, which started with Professor Karl-Göran Tranberg discovering that laser-mediated heat could both destroy cancer and activate the immune system.See details»
Clinical Laserthermia Systems - Crunchbase Company Profile
Contact Email [email protected] Phone Number 046-15 21 00 Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as …See details»
Clinical Laserthermia Systems - Craft
Oct 29, 2024 Clinical Laserthermia Systems has 5 employees across 4 locations and kr8.27 m in annual revenue in FY 2023. See insights on Clinical Laserthermia Systems including office …See details»
CLS focus entirely on its successful neurosurgery business …
Oct 23, 2024 Dan J. Mogren, CEO of CLS, commented: "These strategic decisions make us a leaner, more focused organization, allowing us to channel our resources into a platform …See details»
CLS focus entirely on its successful neurosurgery business …
Oct 23, 2024 Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces it will focus entirely on its successful neurosurgery business to …See details»
CLS: Notice of Extraordinary General Meeting at Clinical …
Sep 9, 2024 Notification can also be made by phone to +46 702 90 33 00 or by email to [email protected] notification should include the shareholder's full name, personal or …See details»
CLS strengthens its organization with Perjan Pleunis as new VP ...
Lund, Sweden, 2021-02-03 - Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for image guided high precision laser ablation, today …See details»
CLS focus entirely on its successful neurosurgery business …
Oct 23, 2024 For more information about CLS, please visit the Company's website: www.clinicallaser.se . This disclosure contains information that CLS is obliged to make public …See details»
Investor Relations - CLS
Investor Relations Clinical Laserthermia Systems (CLS) is listed on Nasdaq First North Growth Market. Our aim is to provide relevant and transparent information for analysts, investors and …See details»
Clinical Laserthermia Systems’ business update: focus on …
Jan 17, 2024 For more information about CLS, please visit the Company's website: www.clinicallaser.se. This disclosure contains information that CLS is obliged to make public …See details»
Clinical Laserthermia Syst. B - placera.se
Jun 14, 2019 The company, which is headquartered in Lund, Sweden and has a subsidiary in Berlin, Germany and Irvine, CA, USA, is listed in Nasdaq First North under the ticker CLS B. …See details»
CLS and Advanced Medical Systems Form Joint Venture …
Aug 24, 2020 T: +46 – (0)702 – 90 33 00 E-mail: [email protected] About Clinical Laserthermia Systems Clinical Laserthermia Systems AB (publ), develops and sells the …See details»
Clinical Laserthermia Systems AB (publ) Reg. no. 556705-8903
Organization, will use the Company’s TRANBERG® Thermal Therapy System and imILT® methodology in conjunction with Immunophotonics’ proprietary drug, IP-001. The study is fully …See details»
Clinical Laserthermia Systems receives FDA 510 (k ... - placera.se
Sep 23, 2022 Tel: +46 – (0)705 – 90 11 40 E-mail: [email protected] About CLS Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal …See details»
CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of
Oct 25, 2021 The Certified Advisor (CA) is FNCA Sweden AB, Tel: +46 8 528 00 399. E-mail: [email protected]. For more information about CLS, please visit the Company's website: …See details»
CLS and Advanced Medical Systems Form Joint Venture
Aug 24, 2020 Further information is available on www.clinicallaser.se. Tags high precision laser ablation MRI-Guided Laser Ablation image-guided laser ablation cancer tumors cancer …See details»
Pipeline - CLS
Jun 27, 2024 Pipeline Research is just the beginning – and that is where it all began for CLS. We are now running various clinical studies to develop new therapies in the fight against …See details»
CLS Americas and URN Announce First Patient Treated in Clinical …
Apr 20, 2022 CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. …See details»